Midostaurin

TypeName: Business Offer
Category:
Offer Date:2018/09/29
Country: United States
Summary: Midostaurin is a multi-target protein kinase inhibitor being investigated for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
https://www.bocsci.com/midostaurin-cas-120685-11-2-item-162132.html
Description: [RequestDescription]
OfferId: 2152
Name:Alex Brown
Telphone:
Categories